IMCR logo

IMCR
Immunocore Holdings PLC - ADR

521
Mkt Cap
$1.57B
Volume
268,470.00
52W High
$40.71
52W Low
$26.37
PE Ratio
-43.82
IMCR Fundamentals
Price
$31.05
Prev Close
$31.81
Open
$31.84
50D MA
$31.76
Beta
0.70
Avg. Volume
380,964.61
EPS (Annual)
-$0.707
P/B
4.15
Rev/Employee
$765,173.26
$1,320.03
Loading...
Loading...
News
all
press releases
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Consensus Recommendation of "Hold" by Brokerages
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Get Free Report) has received a consensus recommendation of "Hold" from the thirteen brokerages that are currently covering the firm...
MarketBeat·11d ago
News Placeholder
More News
News Placeholder
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Short Interest Down 15.4% in March
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Get Free Report) was the target of a significant decline in short interest in March. As of March 13th, there was short interest totaling...
MarketBeat·11d ago
News Placeholder
Immunocore (NASDAQ:IMCR) Cut to "Hold" at Jefferies Financial Group
Jefferies Financial Group cut Immunocore from a "buy" rating to a "hold" rating and set a $33.00 target price on the stock. in a research note on Monday...
MarketBeat·26d ago
News Placeholder
What is HC Wainwright's Estimate for Immunocore Q1 Earnings?
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Free Report) - Investment analysts at HC Wainwright raised their Q1 2026 earnings per share (EPS) estimates for shares of Immunocore in a report...
MarketBeat·1mo ago
News Placeholder
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Get Free Report) have earned an average recommendation of "Moderate Buy" from the thirteen research firms that are covering the firm...
MarketBeat·1mo ago
News Placeholder
FY2027 EPS Estimates for Immunocore Cut by HC Wainwright
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Free Report) - Equities researchers at HC Wainwright cut their FY2027 earnings per share (EPS) estimates for Immunocore in a report issued on...
MarketBeat·1mo ago
News Placeholder
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types PR Newswire VANCOUVER...
PR Newswire·1mo ago
News Placeholder
Immunocore (NASDAQ:IMCR) Downgraded by Zacks Research to "Hold"
Zacks Research cut Immunocore from a "strong-buy" rating to a "hold" rating in a research note on Wednesday...
MarketBeat·1mo ago
News Placeholder
Immunocore (NASDAQ:IMCR) Given New $75.00 Price Target at Needham & Company LLC
Needham & Company LLC boosted their target price on shares of Immunocore from $71.00 to $75.00 and gave the company a "buy" rating in a report on Thursday...
MarketBeat·1mo ago
News Placeholder
Immunocore Q4 Earnings Call Highlights
Immunocore (NASDAQ:IMCR) executives highlighted continued commercial momentum for KIMMTRAK and progress across a diversified pipeline during the company's fourth-quarter and full-year 2025 earnings...
MarketBeat·1mo ago
<
1
2
...
>

Latest IMCR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.